Conditional cancer-specific mortality in T4, N1, or M1 prostate cancer: implications for long-term prognosis.

scientific article published on 30 July 2015

Conditional cancer-specific mortality in T4, N1, or M1 prostate cancer: implications for long-term prognosis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1012523433
P356DOI10.1186/S13014-015-0470-0
P932PMC publication ID4518568
P698PubMed publication ID26220664
P5875ResearchGate publication ID280588027

P50authorBrandon A MahalQ85643167
P2093author name stringPaul L Nguyen
Vinayak Muralidhar
P2860cites workFear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer.Q50894166
Patients with prostate cancer continue to have excess mortality up to 15 years after diagnosisQ61912501
Multiple correlations and Bonferroni's correctionQ77496506
Stage IV prostate cancer: survival differences in clinical T4, nodal and metastatic diseaseQ84556406
The effect of prostate cancer screening on stage IV disease in AmericaQ85232995
Validation of TNM classification for metastatic prostatic cancer treated using primary androgen deprivation therapyQ85319717
Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based studyQ30457185
Conditional survival for longer-term survivors from 2000-2004 using population-based cancer registry data in Osaka, JapanQ30651612
Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis.Q33812024
Conditional survival of cancer patients: an Australian perspectiveQ34435964
Effect of very small tumor size on cancer-specific mortality in node-positive breast cancerQ35114439
Conditional survival among cancer patients in the United StatesQ35584226
Cancer disparities by race/ethnicity and socioeconomic statusQ35733898
Conditional Survival in Rectal Cancer: A SEER Database Analysis.Q37077208
Coded tumor size may be unreliable for small metastatic renal cancers in the Surveillance, Epidemiology, and End Results datasetQ37632950
Prognosis for long-term survivors of cancerQ44074635
Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapyQ45411118
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P304page(s)155
P577publication date2015-07-30
P1433published inRadiation OncologyQ2313370
P1476titleConditional cancer-specific mortality in T4, N1, or M1 prostate cancer: implications for long-term prognosis
P478volume10

Reverse relations

cites work (P2860)
Q46873895Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; A time to sub-classify stage IV?
Q90056954Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy
Q39038671Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer
Q38766786Patient survival and risk of death after prostate cancer treatment in the Brazilian Unified Health System

Search more.